4.7 Letter

Comparative Effectiveness Research to Position Therapies in Ulcerative Colitis: How Fair Are the Comparisons?

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study

Tessa Straatmijer et al.

Summary: This study compared the effectiveness and safety of vedolizumab and tofacitinib in anti-TNF-exposed patients with UC. The results showed that tofacitinib was associated with superior effectiveness outcomes compared with vedolizumab, along with comparable safety outcomes.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Review Gastroenterology & Hepatology

Breaking the therapeutic ceiling in drug development in ulcerative colitis

Dahham Alsoud et al.

Summary: This article discusses the limitations of therapeutic efficacy in ulcerative colitis treatment, the shortcomings of current strategies, and proposes solutions for improving therapeutic outcomes.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Pharmacology & Pharmacy

Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?

Dahham Alsoud et al.

CURRENT OPINION IN PHARMACOLOGY (2020)

Article Public, Environmental & Occupational Health

Variable selection for propensity score models

M. Alan Brookhart et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)